Cover Image

Planning and analyzing clinical trials with composite endpoints

Show other versions (1)

Intro -- Preface -- Contents -- Part I General Introduction to Composite Endpoints -- 1 Definition and Rationale -- 1.1 Definitions and Types of Composite Endpoints -- 1.1.1 Composite Binary Event Endpoints -- 1.1.2 Composite Time-to-First-Event Endpoints -- 1.1.3 A Note on Clinical Scores -- 1.2 Ra...

Full description

Saved in:
Bibliographic Details
Main Author: Rauch, Geraldine (Author)
Other Authors: Schüler, Svenja (Contributor) , Kieser, Meinhard (Contributor)
Format: Book/Monograph
Language:English
Published: Cham Springer 2019
Series:Springer Series in Pharmaceutical Statistics
Online Access: Get full text
Author Notes:by Geraldine Rauch, Svenja Schüler, Meinhard Kieser

MARC

LEADER 00000cam a2200000 c 4500
001 1787029913
003 DE-627
005 20241107233451.0
007 tu
008 220124s2019 xx ||||| 00| ||eng c
020 |a 9783319737690  |9 978-3-319-73769-0 
035 |a (DE-627)1787029913 
035 |a (DE-599)KXP1787029913 
035 |a (OCoLC)1376510847 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
072 7 |a PBT  |2 bicssc 
072 7 |a MED090000  |2 bisacsh 
082 0 |a 615.50724 
084 |a 33  |2 sdnb 
100 1 |a Rauch, Geraldine  |e VerfasserIn  |0 (DE-588)139823492  |0 (DE-627)61378944X  |0 (DE-576)313422923  |4 aut 
245 1 0 |a Planning and analyzing clinical trials with composite endpoints  |c by Geraldine Rauch, Svenja Schüler, Meinhard Kieser 
264 1 |a Cham  |b Springer  |c 2019 
300 |a xvi, 255 Seiten  |b Illustrationen 
336 |a Text  |b txt  |2 rdacontent 
337 |a ohne Hilfsmittel zu benutzen  |b n  |2 rdamedia 
338 |a Band  |b nc  |2 rdacarrier 
490 0 |a Springer Series in Pharmaceutical Statistics 
500 |a Description based on publisher supplied metadata and other sources 
520 |a Intro -- Preface -- Contents -- Part I General Introduction to Composite Endpoints -- 1 Definition and Rationale -- 1.1 Definitions and Types of Composite Endpoints -- 1.1.1 Composite Binary Event Endpoints -- 1.1.2 Composite Time-to-First-Event Endpoints -- 1.1.3 A Note on Clinical Scores -- 1.2 Rationale for the Use of Composite Endpoints -- 1.2.1 Augmenting Power -- 1.2.2 Avoiding Multiplicity -- References -- 2 Challenges of Composite Endpoints -- 2.1 Uncertainties in the Planning Stage -- 2.2 Interpretation of Results -- 2.3 Competing Risks as a Source of Bias -- 2.4 Follow-Up Beyond the First Event -- References -- 3 Guideline View: Recommendations and Requirements -- 3.1 Guidelines Related to Composite Endpoints -- 3.2 Guideline Recommendations -- 3.3 Beyond the Guidelines: Open Issues -- References -- 4 Clinical Trial Examples -- 4.1 The Osteoporosis Trial -- 4.2 The MOMS Trial -- 4.3 The OMEGA Trial -- 4.4 The RENAAL Trial -- 4.5 The DREAM Trial -- 4.6 The CAPRICORN Trial -- 4.7 The LIFE Trial -- References -- Part II Confirmatory Test Problem for a Single (Composite) Endpoint -- 5 The Single-Stage Design -- 5.1 Binary Endpoints -- 5.1.1 Test Problem -- 5.1.2 Test Statistics -- 5.1.3 Sample Size Calculation -- 5.1.3.1 Standard Sample Size Calculation -- 5.1.3.2 Robust Sample Size Calculation -- 5.2 Time-to-Event Endpoints Under Proportional Hazards -- 5.2.1 Test Problem -- 5.2.2 Test Statistics -- 5.2.3 Sample Size Calculation -- 5.2.3.1 Standard Sample Size Calculation -- 5.2.3.2 Robust Sample Size Calculation -- 5.3 Time-to-Event Endpoints for Non-proportional Hazards -- 5.3.1 Test Problem -- 5.3.2 Test Statistics -- 5.3.3 Sample Size Calculation -- 5.4 Recurrent Event Analysis -- References -- 6 Group-Sequential and Adaptive Designs -- 6.1 Stage-Wise Local Levels -- 6.1.1 Choice of Stage-Wise Local Levels. 
650 4 |a Clinical trials-Statistical methods 
700 1 |a Schüler, Svenja  |e MitwirkendeR  |0 (DE-588)1110218494  |0 (DE-627)864824718  |0 (DE-576)475751493  |4 ctb 
700 1 |a Kieser, Meinhard  |d 1960-  |e MitwirkendeR  |0 (DE-588)103276547X  |0 (DE-627)739277766  |0 (DE-576)168963825  |4 ctb 
776 0 8 |i Erscheint auch als  |n Online-Ausgabe  |a Rauch, Geraldine  |t Planning and analyzing clinical trials with composite endpoints  |d Cham : Springer, 2017  |h Online-Ressource (XVI, 255 p. 9 illus., 2 illus. in color, online resource)  |w (DE-627)1657093719  |w (DE-576)505932091  |z 9783319737706 
951 |a BO 
992 |a 20230420 
993 |a Book 
998 |g 103276547X  |a Kieser, Meinhard  |m 103276547X:Kieser, Meinhard  |d 910000  |d 999701  |e 910000PK103276547X  |e 999701PK103276547X  |k 0/910000/  |k 1/910000/999701/  |p 3  |y j 
998 |g 1110218494  |a Schüler, Svenja  |m 1110218494:Schüler, Svenja  |d 50000  |e 50000PS1110218494  |k 0/50000/  |p 2 
998 |g 139823492  |a Rauch, Geraldine  |m 139823492:Rauch, Geraldine  |d 50000  |e 50000PR139823492  |k 0/50000/  |p 1  |x j 
999 |a KXP-PPN1787029913  |e 4311706111 
BIB |a Y 
JSO |a {"name":{"displayForm":["by Geraldine Rauch, Svenja Schüler, Meinhard Kieser"]},"origin":[{"dateIssuedDisp":"2019","publisher":"Springer","publisherPlace":"Cham","dateIssuedKey":"2019"}],"type":{"bibl":"book"},"title":[{"title_sort":"Planning and analyzing clinical trials with composite endpoints","title":"Planning and analyzing clinical trials with composite endpoints"}],"id":{"eki":["1787029913"],"isbn":["9783319737690"]},"person":[{"display":"Rauch, Geraldine","family":"Rauch","given":"Geraldine","role":"aut"},{"display":"Schüler, Svenja","given":"Svenja","family":"Schüler","role":"ctb"},{"family":"Kieser","given":"Meinhard","display":"Kieser, Meinhard","role":"ctb"}],"recId":"1787029913","language":["eng"],"note":["Description based on publisher supplied metadata and other sources"],"physDesc":[{"noteIll":"Illustrationen","extent":"xvi, 255 Seiten"}]} 
SRT |a RAUCHGERALPLANNINGAN2019 

Similar Items